{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:00:20Z","timestamp":1777550420021,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Taiwan Ministry of Science Technology","doi-asserted-by":"crossref","award":["103-2325-B-400-010-CC2"],"award-info":[{"award-number":["103-2325-B-400-010-CC2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004663","name":"Taiwan Ministry of Science Technology","doi-asserted-by":"crossref","award":["103-2311-B-400-004-MY3"],"award-info":[{"award-number":["103-2311-B-400-004-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.antiviral.2016.03.011","type":"journal-article","created":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T08:40:26Z","timestamp":1458376826000},"page":"27-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Immunogenicity of an adeno-vector vaccine expressing the F protein of a respiratory syncytial virus manufactured from serum-free suspension culture"],"prefix":"10.1016","volume":"130","author":[{"given":"Hsiao-Yun","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huai-Sheng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Ling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-Rung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Chieh","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Kun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6257-0389","authenticated-orcid":false,"given":"Chia-Chyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Hung","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.03.011_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/hum.2005.16.149","article-title":"Adenovirus vector-based vaccines for human immunodeficiency virus type 1","volume":"16","author":"Barouch","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.antiviral.2016.03.011_bib2","first-page":"152","article-title":"The cotton rat model of respiratory viral infections. Biologicals","volume":"37","author":"Boukhvalova","year":"2009","journal-title":"J.\u00a0Int. Assoc. Biol. Stand."},{"key":"10.1016\/j.antiviral.2016.03.011_bib3","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.4049\/jimmunol.1203140","article-title":"Antigen-specific memory regulatory CD4+Foxp3+ T cells control memory responses to influenza virus infection","volume":"190","author":"Brincks","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.03.011_bib4","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.4049\/jimmunol.167.8.4254","article-title":"Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection","volume":"167","author":"Chang","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.03.011_bib5","first-page":"291","article-title":"Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiologic aspects of infection in infants and young children","volume":"66","author":"Chanock","year":"1957","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2016.03.011_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/(SICI)1097-0290(19980905)59:5<567::AID-BIT6>3.0.CO;2-8","article-title":"Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells","volume":"59","author":"Cote","year":"1998","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.antiviral.2016.03.011_bib7","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jphp.12350","article-title":"Adenoviral vectors as novel vaccines for influenza","volume":"67","author":"Coughlan","year":"2015","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.antiviral.2016.03.011_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nm.1894","article-title":"Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease","volume":"15","author":"Delgado","year":"2009","journal-title":"Nat. Med."},{"issue":"Suppl.\u00a0l","key":"10.1016\/j.antiviral.2016.03.011_bib9","first-page":"77","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"31","author":"Falsey","year":"2005","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.antiviral.2016.03.011_bib10","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/515286","article-title":"Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization","volume":"177","author":"Gallichan","year":"1998","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.03.011_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-065X.2010.00972.x","article-title":"Biological challenges and technological opportunities for respiratory syncytial virus vaccine development","volume":"239","author":"Graham","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.antiviral.2016.03.011_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/163.4.693","article-title":"Immunity to and frequency of reinfection with respiratory syncytial virus","volume":"163","author":"Hall","year":"1991","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.03.011_bib13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(63)92239-6","article-title":"The isolation of respiratory syncytial virus from children with acute respiratory disease","volume":"1","author":"Holzel","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.03.011_bib14","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1086\/514115","article-title":"Development of a humanized monoclonal antibody (MEDI-493) with potent in\u00a0vitro and in\u00a0vivo activity against respiratory syncytial virus","volume":"176","author":"Johnson","year":"1997","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.03.011_bib15","doi-asserted-by":"crossref","first-page":"12601","DOI":"10.1128\/JVI.01036-09","article-title":"Protective efficacy and immunogenicity of an adenoviral vector vaccine encoding the codon-optimized F protein of respiratory syncytial virus","volume":"83","author":"Kohlmann","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.03.011_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/mthe.2001.0516","article-title":"Improvement in adenoviral gene transfer efficiency after preincubation at\u00a0+37 degrees C in\u00a0vitro and in\u00a0vivo","volume":"5","author":"Kossila","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2016.03.011_bib17","doi-asserted-by":"crossref","first-page":"e30507","DOI":"10.1371\/journal.pone.0030507","article-title":"Human SCARB2-mediated entry and endocytosis of EV71","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.03.011_bib18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.03.011_bib19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/(SICI)1097-0290(19960920)51:6<613::AID-BIT1>3.0.CO;2-K","article-title":"Improvement of recombinant protein production with the human adenovirus\/293S expression system using fed-batch strategies","volume":"51","author":"Nadeau","year":"1996","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.antiviral.2016.03.011_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.coviro.2011.12.008","article-title":"Structure of human adenovirus","volume":"2","author":"Nemerow","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2016.03.011_bib21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/CMR.18.3.541-555.2005","article-title":"Immune responses and disease enhancement during respiratory syncytial virus infection","volume":"18","author":"Openshaw","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2016.03.011_bib22","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.20020781","article-title":"A\u00a0role for immune complexes in enhanced respiratory syncytial virus disease","volume":"196","author":"Polack","year":"2002","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.antiviral.2016.03.011_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0168-1702(85)90045-0","article-title":"Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat","volume":"3","author":"Prince","year":"1985","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2016.03.011_bib24","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1126\/science.1187292","article-title":"Crystal structure of human adenovirus at 3.5 A resolution","volume":"329","author":"Reddy","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.03.011_bib25","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1099\/0022-1317-81-11-2573","article-title":"Update on adenovirus and its vectors","volume":"81","author":"Russell","year":"2000","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2016.03.011_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1008021428969","article-title":"A\u00a0high-yielding serum-free, suspension cell culture process to manufacture recombinant adenoviral vectors for gene therapy","volume":"28","author":"Schoofs","year":"1998","journal-title":"Cytotechnology"},{"key":"10.1016\/j.antiviral.2016.03.011_bib27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/hum.1997.8.4-453","article-title":"Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles","volume":"8","author":"Shabram","year":"1997","journal-title":"Hum. Gene Ther."},{"issue":"40","key":"10.1016\/j.antiviral.2016.03.011_bib28","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1016\/j.vaccine.2009.07.004","article-title":"Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses","volume":"27","author":"Shao","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.03.011_bib29","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1128\/JVI.01536-14","article-title":"Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease","volume":"89","author":"Su","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.03.011_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003692","article-title":"Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease","volume":"9","author":"Tsou","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2016.03.011_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/rmv.518","article-title":"Immunopathology of RSV infection: prospects for developing vaccines without this complication","volume":"17","author":"van Drunen Littel-van den Hurk","year":"2007","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2016.03.011_bib32","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.vaccine.2004.07.043","article-title":"Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans","volume":"23","author":"Van Kampen","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.03.011_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2015.07.024","article-title":"Antibodies enhance CXCL10 production during RSV infection of infant and adult immune cells","author":"Vissers","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.antiviral.2016.03.011_bib34","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","volume":"173","author":"Wang","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.03.011_bib35","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/CMR.12.3.383","article-title":"Intranasal antibody prophylaxis for protection against viral disease","volume":"12","author":"Weltzin","year":"1999","journal-title":"Clin. Microbiol. Rev."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216301504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216301504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T15:17:18Z","timestamp":1567696638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216301504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":35,"alternative-id":["S0166354216301504"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.03.011","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity of an adeno-vector vaccine expressing the F protein of a respiratory syncytial virus manufactured from serum-free suspension culture","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}